Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Annual Information Service

Malaysia Pharmaceuticals & Healthcare

Published by Fitch Solutions, Inc. Product code 179529
Published annual subscription Content info 66 Pages
Back to Top
Malaysia Pharmaceuticals & Healthcare
Published: annual subscription Content info: 66 Pages

Key View: A number of details combine to ensure Malaysia remains an attractive market for drugmakers in Asia Pacific region, such as the continued growth of an ageing population with more chronic diseases, the ascension of the middle class, expanded healthcare coverage and the rise of healthcare as a national priority. However, expected drug pricing controls along with a turbulent political and economic environment will limit spending on and investment in the pharmaceuticals market.

Table of Contents
Product Code: SSMY03_20210101

Table of Contents

  • Key View
  • Malaysia Pharmaceuticals & Healthcare Covid-19 Impact
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast
  • Industry Risk/Reward Index
  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Innovative Pharmaceuticals Risk/Reward Index
  • Regulatory Development
  • Regulatory Review
  • Market Overview

Competitive Landscape

  • Company Profile
  • Chemical Company Of Malaysia
  • Kotra Pharma
  • Novartis
  • Ranbaxy Malaysia
  • Sanofi
  • Malaysia Demographic Outlook
  • Pharmaceuticals & Healthcare Glossary
  • Pharmaceuticals & Healthcare Methodology
Back to Top